Effects of lamotrigine on the symptoms and life qualities of patients with post polio syndrome: A randomized, controlled study

NeuroRehabilitation

Volumn 20, Issue 4, 2005, Pages 245-251

  On, Arzu Yagiz ^a   Oncu, Julide ^a   Uludag, Burhanettin ^a   Ertekin, Cumhur ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Fatigue; Lamotrigine; Life quality; Post polio syndrome

Indexed keywords

LAMOTRIGINE;

ADULT; ARTICLE; AWARENESS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFECT; EXERCISE; FATIGUE; HEALTH STATUS; HUMAN; MUSCLE CRAMP; PAIN; PHYSICIAN; POSTPOLIOMYELITIS SYNDROME; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE;

EID: 29744458383     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.3233/nre-2005-20402     Document Type: Article

References (38)

1. J. Agre, A.A. Rodriquez and K.B. Sperling, Symptoms and clinical impression of patients seem in a post polio clinic, Arch Phys Med Rehabil 70 (1989), 367-370.
2. J. Agre, A.A. Rodriquez and M.F. Todd, Strength, endurance and work capacity after muscle strengthening exercise in post-polio subjects, Arch Phys Med Rehabil 78 (1997), 681-686.
3. A.P. Aldenkamp and G. Baker, A systematic review of the effects of lamotrigine on cognitive function and quality of life, Epilepsy Behav 2 (2001), 85-91.
4. A.P. Aldenkamp, J. Arends and H.P.R. Bootsma, Randomized Double-blind Parallel-group Study Comparing Cognitive Effects of a Low-dose Lamotrigine with Valproate and Placebo in Healthy Volunteers, Epilepsia 43 (2002), 19-26.
5. A.P. Aldenkamp, O.G. Mulder and J. Overweg, Cognitive effects of lamotrigine as first line add-on in patients with localized related (partial) epilepsy, J Epilepsy 10 (1997), 117-121.
6. G. Blackburn-Munro, T. Dickinson and S.M. Fleetwood-Walker, Non-opioid actions of lamotrigine within the rat dorsal horn after inflammation and neuropathic nerve damage, Neurosci Res 39 (2001), 385-390.
7. D. Bodian and H.A. Howe, Emerging concept of poliomyelitis injection, Science 122 (1955), 105-108.
8. H. Burger and C. Marincek, The influence of post-polio syndrome on independence and life satisfaction, Disabil Rehabil 22 (2000), 318-322.
9. J.R. Calabrese, C.L. Bowden and G.S. Sachs, A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar depression, J Clin Psychiatry 60 (1999), 79-88.
10. S.Y. Chipchase, N.B. Lincoln and K.A. Radford, Measuring fatigue in people with multiple sclerosis, Disabil Rehabil 25 (2003), 778-784.
11. D.W. Choi, Excitotoxic cell death, J Neurobiol 23 (1992), 1261-1276.
12. M.C. Dalakas, Pathogenic mechanisms of post-polio syndrome: Morphological, electrophysiological, virological, and immunological correlations, Ann NY Acad Sci 753 (1995), 167-185.
13. E. Eisenberg, Y. Lurie, C. Braker, D. Daoud and A. Ishay, Lamotrigine reduces painful diabetic neuropathy, A randomized, controlled study, Neurology 57 (2001), 505-509.
14. C. Ertekin, A.Y. On, Y. Kirazli, T. Kurt and N. Gurgor, Motor evoked responses from the thigh muscles to the stimulation of the upper limb nerves in patients with late poliomyelitis, Clin Neurophysiol 113 (2002), 478-484.
15. K.L. Goa, S. Ross and P. Chrisp, Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy, Drugs 46 (1993), 152-176.
16. G. Grimby and A.L. Thoren-Jonsson, Disability in poliomyelitis sequelae, Phys Ther 74 (1994), 46-55.
17. L.S. Halstead and C.D. Rossi, New problems in old polio patients: results of a survey of 539 polio survivors, Orthopedics 8 (1985), 845-850.
18. M.J. Hamilton, A.F. Cohen and A.W. Yuen, Carbamazepine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosage, Epilepsia 34 (1993), 166-173.
19. K. Herlofson and J.P. Larsen, Measuring fatigue in patients with Parkinson's disease- the fatigue severity scale, Eur J Neurol 9 (2002), 595-600.
20. C. Ikonomodou and L. Turski, Excitotoxicity and neurodegenerative diseases, Cur Opin Neurol 8 (1995), 487-489.
21. W.J. Koroshetz and M.A. Moskowitz, Emerging treatments for stroke in humans, Trends Pharmacol Sci 17 (1996), 227-233.
22. B. Kremer, C.M. Clark and E.W. Almqvist, Influence of lamotrigine on progression of early Huntington disease. A randomized clinical trial, Neurology 53 (1999), 1000-1008.
23. A.A. Kucukdeveci, S.P. McKenna and S. Kutlay, The development and psychometric assessment of Turkish version of Nottingham Health Profile, Int J Rehabil Res 23 (2000), 31-38.
24. R. Martin, R. Kuzniecky and S. Ho, Cognitive effects of topiramate, gabapentin and lamotrigine in healthy young adults, Neurology 15 (1999), 321-327.
25. A.C. McComas, C. Quartly and C. Griggs, Early and late losses of motor units after poliomyelitis, Brain 120 (1997), 1415-1421.
26. A.C. McComas, J.C. Agre, A.A. Rodriquez and J.A. Tafel, Late effects of polio: critical review of the literature on neuromuscular function, Arch Phys Med Rehabil 72 (1991), 923-931.
27. K.J. Meador, D.W. Loring and P.G. Ray, Differential cognitive and behavioral effects of carbamazepine and lamotrigine, Neurology 56 (2001), 1177-1182.
28. F. Pisani, S. Pedale, V. Macaione and V. Torre, Neuroprotective effects of Lamotrigine and Remacemide on excitotoxicity by glutamate agonists in isolated chick retina, Exp Neurol 170 (2001), 162-170.
29. A.K. Schanke and J.K. Stanghelle, Fatigue in polio survivors, Spinal Cord 39 (2001), 243-251.
30. A.K. Schanke, J.K. Stanghelle, S. Andersson and A. Opheim, Mild versus severe fatigue in polio survivors: special characteristics, J Rehabil Med 34 (2002), 134-140.
31. J.B. Schulz, R. Matthews, D. Henshaw and M.F. Beal, Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases, Neuroscience 71 (1996), 1043-1048.
32. S.E. Smith, B.S. Meldrum and M.B. Chir, Cerebroprotective effect of lamotrigine after focal ischemia in rats, Stroke 26 (1995), 117-121.
33. E. Stalberg and G. Grimby, Dynamic electromyography and muscle biopsy changes in a 4-year follow-up: study of patients with a history of polio, Muscle Nerve 18 (1995), 699-707.
34. A.L. Thoren-Jonsson, M. Hedberg and G. Grimby, Distress in everyday life in people with poliomyelitis sequel, J Rehabil Med 33 (2001), 119-127.
35. K. Vestergaard, G. Andersen and H. Gottrup, Lamotrigine for central poststroke pain a randomized controlled trial, Neurology 56 (2001), 184-190.
36. W.P. Waring, F. Maynard, W. Grady, R. Grady and C. Boyles, Influence of appropriate lower extremity orthotic management on ambulation, pain and fatigue in a postpolio population, Arch Phys Med Rehabil 70 (1989), 371-375.
37. C. Willen, K.S. Sunnerhagen and G. Grimby, Dynamic water exercise in individuals with late poliomyelitis, Arch Phys Med Rehabil 82 (2001), 66-72.
38. I.C. Wong, G.E. Mawer and J.W. Sander, Adverse Event Monitoring in Lamotrigine Patients: A Pharmacoepidemiologic Study in the United Kingdom, Epilepsia 42 (2001), 237-244.